Diana Aguiar de Sousa
Overview
Explore the profile of Diana Aguiar de Sousa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
1603
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saflund M, Matusevicius M, Egido J, Ferro J, Korv J, Melis M, et al.
Eur Stroke J
. 2025 Mar;
:23969873251325978.
PMID: 40087880
Introduction: Data is limited on the safety of early initiation of direct oral anticoagulation (DOAC) treatment after acute ischemic stroke (AIS) receiving reperfusion therapy in patients with atrial fibrillation (AF)....
2.
van de Munckhof A, Sanchez van Kammen M, Tatlisumak T, Krzywicka K, Aaron S, Antochi F, et al.
Lancet Neurol
. 2025 Feb;
24(3):199-207.
PMID: 39986309
Background: There is an unmet need for high-quality data from prospective studies on the safety and effectiveness of direct oral anticoagulants (DOACs) for the treatment of cerebral venous thrombosis (CVT)....
3.
Predictors and outcome of deterioration during admission in patients with cerebral venous thrombosis
Ferro M, Bettencourt S, Soares M, Baptista M, Marques-Matos C, Fragata I, et al.
Eur Stroke J
. 2025 Feb;
:23969873251315340.
PMID: 39932263
Introduction: Cerebral venous thrombosis (CVT) is a less common stroke subtype. While long term outcome factors have been extensively studied, short term deterioration remains poorly understood. Patients And Methods: We...
4.
Aguiar de Sousa D, Zietz A, Zedde M, Katsanos A, Li L, Marti-Fabregas J, et al.
Eur Stroke J
. 2025 Feb;
:23969873251316430.
PMID: 39904756
Promoting the highest quality, evidence-based research across Europe is a priority of the European Stroke Organisation (ESO). The ESO Guideline Board communicate and promote evidence-based recommendations for clinical practice through...
5.
Polymeris A, Branca M, Sylaja P, Sandset E, Aguiar de Sousa D, Thomalla G, et al.
JAMA Netw Open
. 2025 Jan;
8(1):e2456307.
PMID: 39874037
Importance: The net clinical effect of early vs later direct oral anticoagulant (DOAC) initiation after atrial fibrillation-associated ischemic stroke is unclear. Objective: To investigate whether early DOAC treatment is associated...
6.
Brakel B, Rebchuk A, Ospel J, Chen Y, Heran M, Goyal M, et al.
Int J Stroke
. 2024 Nov;
20(3):319-327.
PMID: 39569543
Background: Cerebral venous thrombosis (CVT) accounts for 0.5-1% of all strokes. The role of endovascular therapy (EVT) in the management of CVT remains controversial and variations in practice patterns are...
7.
8.
Rosa S, Fragata I, Aguiar de Sousa D
Curr Opin Neurol
. 2024 Oct;
38(1):18-28.
PMID: 39469812
Purpose Of Review: This review intends to systematize the diagnostic and treatment approach to cerebral venous thrombosis (CVT), highlighting key studies that have been recently published. Recent Findings: In light...
9.
Lindgren E, Shu L, Simaan N, Krzywicka K, de Winter M, Sanchez van Kammen M, et al.
JAMA Neurol
. 2024 Oct;
81(12):1274-1283.
PMID: 39432281
Importance: One of 10 patients develop epilepsy in the late phase after cerebral venous thrombosis (CVT) diagnosis but predicting the individual risk is difficult. Objective: To develop and externally validate...
10.
van de Munckhof A, Sanchez van Kammen M, Krzywicka K, Aaron S, Aguiar de Sousa D, Antochi F, et al.
Front Neurol
. 2024 Oct;
15:1481563.
PMID: 39376688
[This corrects the article DOI: 10.3389/fneur.2023.1251581.].